# A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose

> **NCT05689099** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 20 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Healthy Participants

## Interventions

- **DRUG:** Semaglutide B, 1.34 mg/mL
- **DRUG:** Semaglutide B, 0.68 mg/mL

## Key facts

- **NCT ID:** NCT05689099
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-17
- **Primary completion:** 2023-05-30
- **Final completion:** 2023-05-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05689099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05689099, "A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05689099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*